刘斌, 唐文强, 仝红娟, 朱周静, 唐初. 积雪草酸的结构修饰与生物活性研究进展J. 药学学报, 2022,57(7): 1962-1976. doi: 10.16438/j.0513-4870.2022-0073
引用本文: 刘斌, 唐文强, 仝红娟, 朱周静, 唐初. 积雪草酸的结构修饰与生物活性研究进展J. 药学学报, 2022,57(7): 1962-1976. doi: 10.16438/j.0513-4870.2022-0073
LIU Bin, TANG Wen-qiang, TONG Hong-juan, ZHU Zhou-jing, TANG Chu. Advances in the study of structural modification and biological activities of asiatic acidJ. Acta Pharmaceutica Sinica, 2022,57(7): 1962-1976. doi: 10.16438/j.0513-4870.2022-0073
Citation: LIU Bin, TANG Wen-qiang, TONG Hong-juan, ZHU Zhou-jing, TANG Chu. Advances in the study of structural modification and biological activities of asiatic acidJ. Acta Pharmaceutica Sinica, 2022,57(7): 1962-1976. doi: 10.16438/j.0513-4870.2022-0073

积雪草酸的结构修饰与生物活性研究进展

Advances in the study of structural modification and biological activities of asiatic acid

  • 摘要: 积雪草酸是来自天然植物的乌苏烷型五环三萜,具有多种药理活性,例如抗肿瘤、降糖、抗炎、抗菌等。由于溶解性差、生物利用度低等限制了积雪草酸在临床上的广泛应用。为了克服这些缺点,学者们对其进行了大量的结构修饰与改造,发现了大量结构新颖、活性优良的积雪草酸衍生物。本文综述了积雪草酸近20年来的结构修饰、生物活性、构效关系及作用机制的相关研究进展,以期为积雪草酸类药物开发提供参考。

     

    Abstract: Asiatic acid (AA) is a ursane pentacyclic triterpenoids, which possesses a wide range of pharmacological activities, such as anti-tumor, hypoglycemic, anti-inflammatory, anti-bacterial. Due to poor solubility and low bioavailability, clinical application of asiatic acid is limited. To address these defects, the structural modifications of AA have been carried out, and large numbers of AA-based derivatives with novel structure and eximious biological activity have been developed. In this paper, the research progress of structural modifications, biological activity, structure-activity relationship and mechanism studies in recent twenty years are reviewed, which provides reference for development of AA-related drugs.

     

/

返回文章
返回